Skip to main content
. Author manuscript; available in PMC: 2017 Jan 21.
Published in final edited form as: Pharm Res. 2012 Feb 22;29(7):1821–1831. doi: 10.1007/s11095-012-0706-8

Figure 5.

Figure 5

COS-1 were transfected with 200 ng/ml DNA encoding wt or C270A hASBT and pre-incubated for 10 min with buffer, 3β-Cl-CDCA (50 μM), 7α-Ms-CDCA (50 μM), or the thiol modifying-agent MTSET (1mM). Remaining hASBT activity was measure by TCA uptake. Unlike MTSET, electrophilic CDCA derivatives were able to inactivate both wt and C270A hASBT (n=3, p < 0.01).